| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.81B | +4.1% |
| Cost of Revenue | $8.74B | +3.3% |
| Gross Profit | $2.07B | +7.6% |
| R&D Expense | $413.0M | +3.8% |
| SG&A Expense | $571.0M | +7.7% |
| Operating Income | $1.09B | +11.1% |
| Interest Expense | $103.0M | -4.6% |
| Pre-tax Income | $986.0M | +12.7% |
| Income Tax | $250.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $604.0M | +83.0% |
| Accounts Receivable | $2.24B | +12.2% |
| Inventory | $992.0M | +7.7% |
| Current Assets | $4.10B | +17.7% |
| Total Assets | $8.64B | +10.8% |
| Current Liabilities | $3.92B | +8.0% |
| Long-term Debt | $1.73B | +13.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.16B | +9.3% |
| Capital Expenditures | $441.0M | -23.8% |
| Investing Cash Flow | -$423.0M | +24.9% |
| Financing Cash Flow | -$369.0M | +45.7% |
| Free Cash Flow | $716.0M | +49.2% |
| +10.1% |
| Net Income | $735.0M | +13.8% |
| EPS (Basic) | $9.59 | +19.0% |
| EPS (Diluted) | $9.55 | +18.8% |
| Stockholders' Equity |
| $2.57B |
| +13.0% |